132 related articles for article (PubMed ID: 2117499)
1. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin.
Torr S; Noble MI; Folts JD
Cardiovasc Res; 1990 Jun; 24(6):465-70. PubMed ID: 2117499
[TBL] [Abstract][Full Text] [Related]
2. Dispersion of coronary artery thrombi by antagonism of platelet serotonin receptor in the dog.
Belcher PR; Drake-Holland AJ; Hynd J; Noble MI
Cardiovasc Res; 1992 Mar; 26(3):292-6. PubMed ID: 1423425
[TBL] [Abstract][Full Text] [Related]
3. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
Hsieh CP; Sakai K; Bruns GC; Dage RC
J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754
[TBL] [Abstract][Full Text] [Related]
4. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733.
McBride PA; Mann JJ; Nimchinsky E; Cohen ML
Life Sci; 1990; 47(23):2089-95. PubMed ID: 2125095
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of serotonin in initiation of coronary arterial thrombosis in dog and man.
Noble MI; Drake-Holland AJ
Clin Physiol Biochem; 1990; 8 Suppl 3():50-5. PubMed ID: 1966730
[TBL] [Abstract][Full Text] [Related]
7. Combined inhibitory effects of aspirin and ethanol on adrenaline exacerbation of acute platelet thrombus formation in stenosed canine coronary arteries.
Keller JW; Folts JD
Cardiovasc Res; 1990 Mar; 24(3):191-7. PubMed ID: 2346953
[TBL] [Abstract][Full Text] [Related]
8. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
10. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
[TBL] [Abstract][Full Text] [Related]
11. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
12. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
[TBL] [Abstract][Full Text] [Related]
13. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
Folts JD; Rowe GG
Thromb Res; 1988 May; 50(4):507-16. PubMed ID: 3413717
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
[TBL] [Abstract][Full Text] [Related]
15. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
Yao SK; Ober JC; Gonenne A; Clubb FJ; Krishnaswami A; Ferguson JJ; Anderson HV; Gorecki M; Buja LM; Willerson JT
Circ Res; 1993 Nov; 73(5):952-67. PubMed ID: 8403265
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of the platelet 5HT2 receptor in the presence of thrombolysis.
Belcher PR; Drake-Holland AJ; Noble MI
Int J Cardiol; 1994 Jan; 43(1):11-20. PubMed ID: 8175214
[TBL] [Abstract][Full Text] [Related]
17. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
[TBL] [Abstract][Full Text] [Related]
18. Halothane, but not isoflurane or enflurane, protects against spontaneous and epinephrine-exacerbated acute thrombus formation in stenosed dog coronary arteries.
Bertha BG; Folts JD; Nugent M; Rusy BF
Anesthesiology; 1989 Jul; 71(1):96-102. PubMed ID: 2751146
[TBL] [Abstract][Full Text] [Related]
19. Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.
Bolli R; Ware JA; Brandon TA; Weilbaecher DG; Mace ML
J Am Coll Cardiol; 1984 Jun; 3(6):1417-26. PubMed ID: 6715702
[TBL] [Abstract][Full Text] [Related]
20. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]